TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment

ConclusionsThe advancing global clinical trials using BCG combined with mechanistic data on BCGs induction of Tregs suggests value in this generic drug and possible immune reversal of the type 1 diabetic autoimmune process.

Source: Diabetes/Metabolism Research and Reviews - August 26, 2017 Category: Endocrinology Authors: Denise L. Faustman Tags: REVIEW ARTICLE Source Type: research